Study S001602

A Single-center, Single-arm, Open, Fixed-sequence, Self-controlled Study of the Pharmacokinetic Effects of HRS-1780, Henagliflozin, Metformin, and HRS-7535 in Healthy Subjects

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06495931
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2024-07-15
Primary completion: 2024-08-13
Lead sponsor: Shandong Suncadia Medicine Co., Ltd.
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:HRS-1780 tablets; DRUG:HR20033 tablets; DRUG:HRS-7535 tablets
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

PK parameters：Cmax [0 hour to 24 hours after the last dosing]
PK parameters：AUC0-t [0 hour to 24 hours after the last dosing]
PK parameters：AUC0-∞ [0 hour to 24 hours after the last dosing]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.